GRN

granulin precursor

Basic information

Region (hg38): 17:44345246-44353106

Links

ENSG00000030582NCBI:2896OMIM:138945HGNC:4601Uniprot:P28799AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neuronal ceroid lipofuscinosis 11 (Moderate), mode of inheritance: AR
  • GRN-related frontotemporal lobar degeneration with Tdp43 inclusions (Strong), mode of inheritance: AD
  • neuronal ceroid lipofuscinosis 11 (Moderate), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 11 (Supportive), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 11 (Strong), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis (Definitive), mode of inheritance: AR
  • frontotemporal dementia and/or amyotrophic lateral sclerosis (Definitive), mode of inheritance: AD
  • neuronal ceroid lipofuscinosis 11 (Strong), mode of inheritance: AR
  • GRN-related frontotemporal lobar degeneration with Tdp43 inclusions (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Frontotemporal lobar degeneration with TDP43 inclusions, GRN-related; Neuronal ceroid lipofuscinosis 11AD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic; Ophthalmologic6497355; 9633693; 16862116; 16862115; 16983677; 16401619; 16983685; 16495329; 17436289; 17210807; 18392865; 18543312; 18183624; 18413474; 18703462; 18723524; 19884572; 20142524; 20142525; 22338605; 22366770; 22491866; 22608501; 22647257; 22815225; 22890101; 22906081; 22986778

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GRN gene.

  • not provided (38 variants)
  • GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 (26 variants)
  • GRN-related frontotemporal lobar degeneration with Tdp43 inclusions (26 variants)
  • Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions (24 variants)
  • Frontotemporal dementia (10 variants)
  • GRN-related disorder (3 variants)
  • Primary progressive aphasia (3 variants)
  • Neuronal ceroid lipofuscinosis 11 (2 variants)
  • Inborn genetic diseases (2 variants)
  • Amyotrophic lateral sclerosis type 10 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRN gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
7
clinvar
123
clinvar
130
missense
1
clinvar
240
clinvar
7
clinvar
1
clinvar
249
nonsense
22
clinvar
4
clinvar
2
clinvar
28
start loss
2
clinvar
2
frameshift
44
clinvar
5
clinvar
3
clinvar
52
inframe indel
6
clinvar
6
splice donor/acceptor (+/-2bp)
11
clinvar
12
clinvar
1
clinvar
24
splice region
2
3
17
19
3
44
non coding
7
clinvar
48
clinvar
9
clinvar
64
Total 80 21 266 178 10

Highest pathogenic variant AF is 0.00000659

Variants in GRN

This is a list of pathogenic ClinVar variants found in the GRN region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-44345270-G-T GRN-related frontotemporal lobar degeneration with Tdp43 inclusions • not specified • GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 Benign/Likely benign (May 01, 2024)323529
17-44345286-T-G not specified Benign (May 25, 2017)447474
17-44345297-C-G GRN-related frontotemporal lobar degeneration with Tdp43 inclusions • not specified Likely benign (Nov 24, 2020)323530
17-44345304-T-C GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Benign (Jan 13, 2018)586220
17-44345320-C-T GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Uncertain significance (Apr 27, 2017)888679
17-44345328-G-C Likely benign (Aug 16, 2017)558915
17-44345337-A-C GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Uncertain significance (Apr 27, 2017)888680
17-44345337-A-G Likely pathogenic (Mar 01, 2018)546798
17-44345337-A-T not provided (-)98118
17-44345339-G-A Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Uncertain significance (Apr 12, 2022)1979860
17-44345339-G-C GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Pathogenic (Oct 01, 2007)98119
17-44345347-C-A GRN-related disorder Likely benign (Apr 15, 2019)3046828
17-44345380-G-T GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 Benign (Jan 31, 2021)1612643
17-44345383-C-CG Benign (May 23, 2021)1224905
17-44345570-G-A Likely benign (Oct 11, 2021)1706838
17-44348838-C-G Benign (Aug 31, 2018)1241013
17-44349083-A-G Likely benign (Feb 26, 2020)1197342
17-44349165-A-G GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 Pathogenic (Oct 27, 2021)1352426
17-44349166-T-C GRN-related frontotemporal lobar degeneration with Tdp43 inclusions • Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Pathogenic (Feb 22, 2023)16008
17-44349167-G-A GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Pathogenic (Aug 24, 2006)16009
17-44349169-G-A GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 Pathogenic (Nov 01, 2023)2928811
17-44349170-G-A Likely pathogenic (Dec 01, 2016)447477
17-44349171-A-G Neuronal ceroid lipofuscinosis 11 Uncertain significance (Jan 01, 2016)931001
17-44349172-C-G Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Uncertain significance (Jul 24, 2019)655044
17-44349172-C-T Inborn genetic diseases • Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Uncertain significance (Mar 27, 2023)2522313

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GRNprotein_codingprotein_codingENST00000053867 127857
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.06970.9301257200281257480.000111
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2753413560.9590.00002343881
Missense in Polyphen125126.080.991411498
Synonymous-1.251651461.130.00001081135
Loss of Function3.71829.90.2680.00000157325

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001520.000152
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0002330.000231
European (Non-Finnish)0.0001500.000132
Middle Eastern0.000.00
South Asian0.0001630.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Granulins have possible cytokine-like activity. They may play a role in inflammation, wound repair, and tissue remodeling.;
Disease
DISEASE: Ubiquitin-positive frontotemporal dementia (UP-FTD) [MIM:607485]: Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. It is an autosomal dominant neurodegenerative disease. {ECO:0000269|PubMed:16862116, ECO:0000269|PubMed:16983685, ECO:0000269|PubMed:18183624}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ceroid lipofuscinosis, neuronal, 11 (CLN11) [MIM:614706]: A form of neuronal ceroid lipofuscinosis characterized by rapidly progressive visual loss due to retinal dystrophy, seizures, cerebellar ataxia, and cerebellar atrophy. Cognitive decline may also occur. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material. {ECO:0000269|PubMed:22608501}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Integrated Breast Cancer Pathway;Neutrophil degranulation;Innate Immune System;Immune System (Consensus)

Recessive Scores

pRec
0.430

Intolerance Scores

loftool
0.597
rvis_EVS
-0.46
rvis_percentile_EVS
23.66

Haploinsufficiency Scores

pHI
0.118
hipred
N
hipred_score
0.474
ghis
0.487

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.802

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Grn
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; pigmentation phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
grna
Affected structure
CaP motoneuron
Phenotype tag
abnormal
Phenotype quality
decreased length

Gene ontology

Biological process
signal transduction;regulation of signaling receptor activity;neutrophil degranulation
Cellular component
extracellular region;lysosome;endosome;endoplasmic reticulum;azurophil granule lumen;extracellular exosome
Molecular function
RNA binding;cytokine activity;protein binding;growth factor activity